Edition:
United Kingdom

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

108.52USD
9:02pm BST
Change (% chg)

$-0.86 (-0.79%)
Prev Close
$109.38
Open
$109.63
Day's High
$109.63
Day's Low
$108.46
Volume
180,521
Avg. Vol
201,743
52-wk High
$109.69
52-wk Low
$71.29

Chart for

About

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD),... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $10,992.71
Shares Outstanding(Mil.): 142.30
Dividend: 0.35
Yield (%): 1.81

Financials

  RMD.N Industry Sector
P/E (TTM): 32.15 148.52 32.76
EPS (TTM): 2.40 -- --
ROI: 11.95 9.38 14.61
ROE: 18.73 14.71 16.34

BRIEF-Resmed Inc Q3 GAAP Earnings Per Share $0.76

* RESMED INC ANNOUNCES RESULTS FOR THE THIRD QUARTER OF FISCAL YEAR 2018

26 Apr 2018

BRIEF-Resmed Says Co Entered Certain Amended And Restated Credit Agreement, Dated As Of Closing Date

* RESMED SAYS ON APRIL 17, 2018 ('CLOSING DATE'), CO ENTERED CERTAIN AMENDED AND RESTATED CREDIT AGREEMENT, DATED AS OF CLOSING DATE - SEC FILING

19 Apr 2018

BRIEF-ResMed Hires Bobby Ghoshal As First Chief Technology Officer

* RESMED HIRES BOBBY GHOSHAL AS FIRST CHIEF TECHNOLOGY OFFICER Source text for Eikon: Further company coverage:

02 Apr 2018

BRIEF-ResMed Q2 Gaap Earnings Per Share $0.07

* ANNOUNCES RESULTS FOR THE SECOND QUARTER OF FISCAL YEAR 2018

22 Jan 2018

Earnings vs. Estimates